Navigation Links
EarlySense's EverOn(R) Central Display Station (CDS) Receives FDA Clearance
Date:10/4/2010

EarlySense's EverOn(R) Central Display Station (CDS) Receives FDA Clearance -- RAMAT GAN, Israel, October 4, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, New Products & Services, FDA Approval Click to view news release full screen  

EarlySense's EverOn(R) Central Display Station (CDS) Receives FDA Clearance

   

The CDS Enables Crucial Patient Safety Information and Deterioration Alerts From the Bedside Monitor to Appear on Multiple Displays on the General Care Floor and on the Nurses' Mobile Phones

RAMAT GAN, Israel, October 4, 2010 /PRNewswire/ -- EarlySense announced today that its EverOn Central Display Station (CDS) has been cleared for marketing by the U.S. Food and Drug Administration (FDA). The FDA clearance covers the ability of the system to collect real time vital sign information from up to 36 EverOn bedside monitors and display the information on a computer screen at the nurse's station. This data is also replicated on large LCD displays on the medical surgical floors enabling the clinical teams, as they move from room to room, to continuously and actively observe the condition status of their various patients and any corresponding patient safety alerts. The data is collected by the EverOn system's contact-free sensor placed under the hospital bed mattress. It has no leads or cuffs and never touches the patient.

"Today's FDA clearance news allows us to provide hospitals with a comprehensive solution that enables proactive patient care. This is achieved by delivering critical vital sign and patient safety information from the bedside to the nurses and physicians, wherever they are. With today's increased focus on improved quality and patient safety targets coupled with the challenges of shrinking budgets, hospitals are turning to advanced technologies such as EverOn to provide effective alerts on high risk situations," said Mr. Avner Halperin, CEO of EarlySense.

The Central Display Station is a vital part of EarlySense's EverOn patient monitoring system. It continuously presents and transmits the respiratory and heart rate data of patients. In addition, it displays bed exit alerts for preselected patients. This information helps to minimize falls. Furthermore, the CDS alerts nurses when the system has determined that patients, who are under a pressure ulcer prevention program, need to be turned. This helps nurses to more proactively attend to these patients. Finally, EarlySense's EverOn system is now becoming an integral part of the nurses' workflow as, via the CDS, it sends relevant alerts to the mobile phones of the nurses, enabling real time notification of any adverse changes in a patient's vital signs.

"The Joint Commission national patient safety goals 9, 14 and standard of care PC.02.01.19 require hospitals to reduce patient falls, pressure ulcers, and have a process for early recognition of patient deterioration. A continuous monitoring system that alerts on patient vital signs, bed exits and turns is a crucial tool in proactively complying with these guidelines," said Dalia Argaman, vice president of clinical and regulatory affairs at EarlySense.

The newly cleared CDS augments the EverOn contact-free, patient supervision system approved in June 2010. Clinical evaluations performed worldwide with EverOn show significant improvement in clinical and economic outcomes for hospitals using the system.

About EarlySense:

EarlySense is bringing to market an innovative technology designed to advance proactive and preventive patient supervision to enable better patient outcomes. The company's flagship product, EverOn, is an automatic, continuous, contact-free patient supervision device that follows and documents a patient's vital signs and movement. There are no leads or cuffs to connect to the patient, who has complete freedom of movement and is not burdened by any irritating attachments. The system is currently installed at several medical centers in the USA and Europe. EarlySense is headquartered in Ramat-Gan, Israel.

For additional information, please visit http://www.earlysense.com.

Press contact: Marjie Hadad, media liaison, marjie.hadad@earlysense.com or +972-54-536-5220.


'/>"/>
SOURCE EarlySense
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Top Biopharma Company Adopts BioFortis Translational Research Software for Centralized Management and Mining of Clinical Biomarker Data
2. ICON Opens Full Service Central Laboratory in India
3. Pioneering Cancer Center Introduces Advanced Varian RapidArc(TM) Treatments for Cancer Patients in Central Germany
4. Health Robotics Expands i.v.STATION(TM) Partnership With Can-Med in 10 Countries Within Central Asia
5. Bio-Tech Medical Software, Inc. Biometrics Joins Forces with the University of Central Florida to Fight Diversion and Help Combat Prescription Narcotic Drug Abuse
6. ACM Global Central Lab Announces Partnership with Chindexs United Family Hospitals in China
7. GenVault Corporation Launches its Latest Centralized and Standardized Software Solution for Biobanking and Biological Sample Management, GenConnect 3.2
8. Medical Simulation Corporation to Introduce Central Line Management Program at the National Teaching Institute and Critical Care Exposition
9. ICON Central Laboratories in Singapore Moves to New Facility to Meet Growing Demand
10. MacroGenics Announces the Initiation of a Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Monoclonal Antibody MGAWN1 in Subjects with Suspected Central Nervous System Infection Due to West Nile Virus
11. Sinovac Obtains Initial Order of H1N1 Vaccine from Chinese Central Government
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... ... 2017 , ... Avery Products Corporation, the world’s largest supplier ... is proud to announce that it has won two more awards for its ... avery.com/GHS . The products were recently honored with the ASSE Safety 2017 ...
(Date:7/26/2017)... ... July 25, 2017 , ... ... will garner a better understanding of the considerations needed for designing ideal guide ... The use of CRISPR-Cas9 to create targeted double-strand breaks in genomic DNA has ...
(Date:7/26/2017)... ... July 26, 2017 , ... NLP ... the years of diagnostic excellence by Mayo Clinic and the experience in developing ... will be distributed through the Microsoft Azure platform and will focus on assisting ...
(Date:7/26/2017)... , July 26, 2017  Nurse practitioners play a ... the findings of a Merck Manuals survey released ... medical conference, revealed that most (88 percent) believe they spend ... treatments and prescriptions. ... Merck Manuals survey of 210 nurse ...
Breaking Biology Technology:
(Date:4/5/2017)... 2017 Today HYPR Corp. , leading ... component of the HYPR platform is officially FIDO® ... security architecture that empowers biometric authentication across Fortune 500 ... secured over 15 million users across the financial services ... home product suites and physical access represent a growing ...
(Date:4/4/2017)... 4, 2017   EyeLock LLC , a leader ... United States Patent and Trademark Office (USPTO) has issued ... linking of an iris image with a face image ... the company,s 45 th issued patent. ... timely given the multi-modal biometric capabilities that have recently ...
(Date:3/30/2017)... , March 30, 2017  On April 6-7, 2017, ... the Genome hackathon at Microsoft,s headquarters in ... competition will focus on developing health and wellness apps ... Hack the Genome is the first hackathon ... The world,s largest companies in the genomics, tech and ...
Breaking Biology News(10 mins):